ASP Isotopes (ASPI) Return on Sales (2023 - 2026)

ASP Isotopes' Return on Sales history runs 4 years deep, the most recent figure standing at 0.05% for Q1 2026.

• On a quarterly basis, Return on Sales rose 10.0% year-over-year to 0.05% in Q1 2026; TTM through Mar 2026 was 0.04%, a 2.0% increase from a year earlier, with the FY2025 full-year figure at 0.05%, up 3.0% from the prior year.
• Return on Sales grew to 0.05% in Q1 2026 per ASPI's latest filing, from 0.02% in the prior quarter.
• Across five years, Return on Sales topped out at 0.05% in Q1 2026 and bottomed at 0.63% in Q2 2025.
• The 4-year median for Return on Sales is 0.07% (2024), against an average of 0.11%.
• Across the five-year window, Return on Sales sank 54 bps in 2025 and advanced 10 bps in 2026, its largest moves.
• Year by year, Return on Sales stood at 0.1% in 2023, then rose by 19 bps to 0.08% in 2024, then soared by 77 bps to 0.02% in 2025, then jumped by 364 bps to 0.05% in 2026.
• Per Business Quant, the three latest ASPI Return on Sales figures stand at 0.05% (Q1 2026), 0.02% (Q4 2025), and 0.03% (Q3 2025).